Divisions over lecanemab: keeping an open mind

Lancet. 2024 Sep 21;404(10458):1077. doi: 10.1016/S0140-6736(24)02075-0.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized* / pharmacology
  • Humans

Substances

  • lecanemab
  • Antibodies, Monoclonal, Humanized